21 October 2017
News and Views
Links and Services
fiogf49gjkf04A study reported in the most recent issue of the Alimentary Pharmacology & Therapeutics focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Front-line therapy with mycophenolate mofetil in autoimmune hepatitis has shown high on
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors